Warning!
This is an older article that may not reflect Dr. Mercola’s current view on this topic.
Use our search engine to find Dr. Mercola’s latest position on any health topic.
You will be redirected to the article in seconds
WARNING!
This is an older article that may not reflect Dr. Mercola’s current view on this topic. Use our search engine to find Dr. Mercola’s latest position on any health topic.
1 According to recent research and clinical experimentation, high-dose treatment with the following has been shown to significantly improve COVID-19 outcomes:
Recent research suggests melatonin may be an important adjunct to COVID-19 treatment. Patients hospitalized with COVID-19 pneumonia who were given high-dose melatonin as an adjunct therapy to standard of care improved within four to five days, and all survived. Doctors are also reporting a high degree of success using high-dose melatonin in their COVID-19 treatment. Learn more.
By continuing to browse our site you agree to our use of cookies, revised Privacy Policy and Terms of Service.
I agree
English
Español
Français
Italiano
Polski
Português
한국어
Please Sign in or Join to continue.